Home Combat Arthritis Kevzara Fails COVID-19 Patients for the Last Time

Kevzara Fails COVID-19 Patients for the Last Time

Sep 04, 2020 comments off

Kevzara Fails COVID-19 Patients for the Last Time

Sanofi and Regeneron reported a phase 3 failure with their rheumatoid arthritis treatment and severely affected COVID-19 patients.

Read More…

You May Also Like

COVID-19 patients are developing ‘brain fog.’ But what does that mean?

FDA Authorizes Arthritis Drug Combo for COVID-19

Scientists discover the surprising way young alligators regrow missing tails – CNET

U.S. infectious disease group backs Gilead's remdesivir for COVID-19 treatment – Reuters

St. Jude scientists make breakthrough and discover possible COVID-19 treatment – WBAY

Arthritis drug reinforces our last line of defense against superbugs